Evidence map›Paper›PMID 42390713›Full record

ArticleEpilepsia open2026

Polypharmacy burden and incident epilepsy among older adults in the United States.

Galen Shearn-Nance, Long Vu, Hannah L Fein, Wyatt P Bensken, Jorden G Rieke, Martha Sajatovic, Gena Ghearing, David F Warner, Siran M Koroukian, Nicholas K Schiltz

Abstract read
In one paragraph

Article in Epilepsia open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Galen Shearn-NanceCase Western Reserve University School of Medicine, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0003-1836-5262
Long VuDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.ORCID https://orcid.org/0009-0004-2433-0685
Hannah L FeinDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.ORCID https://orcid.org/0009-0006-5907-3951
Wyatt P BenskenDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0002-2597-9732
Jorden G RiekeFrances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0001-6813-9699
Martha SajatovicCase Western Reserve University School of Medicine, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0002-3073-668X
Gena GhearingDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID https://orcid.org/0000-0002-4477-2868
David F WarnerDepartment of Sociology, University of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID https://orcid.org/0000-0002-8658-2237
Siran M KoroukianDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0002-8106-9581
Nicholas K SchiltzDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0003-0122-6477

Funding

CDC HHS 5 U48 DP006404-03S7NCCDPHP CDC HHS U48 DP006404
6 · The paper itself

Abstract

objectivesTo estimate the prevalence of polypharmacy among older adults with incident epilepsy and to describe the most common combinations of drug classes filled prior to epilepsy diagnosis. Polypharmacy-the concurrent use of multiple medications-is common in older adults with epilepsy, but little is known about its burden and specific patterns at the time of diagnosis.

methodsThis retrospective longitudinal cohort study included 2 768 656 US Medicare beneficiaries aged 67 and older with Part D coverage. Beneficiaries were epilepsy-free from 2016 to 2018; 13 819 (0.5%) were newly diagnosed with epilepsy in 2019. The prevalence of polypharmacy and combinations of therapeutic drug classes filled in 2018 were compared between those with and without incident epilepsy using frequent itemset mining and regression models to estimate adjusted rate ratios.

resultsBeneficiaries with incident epilepsy filled prescriptions for a greater number of therapeutic drug classes in the year prior to diagnosis compared with those without epilepsy (median 9 [IQR 5-12] vs. 6 [IQR 3-9]) and were more likely to have filled prescriptions for five or more distinct drug classes (81.4% vs. 63.3%). Antidepressants, gastric medications, and loop diuretics were more prevalent among beneficiaries with incident epilepsy. The combination of calcium channel blockers and antihypertensives was most strongly associated with incident epilepsy after adjustment (adjusted rate ratio 1.54 [99% CI, 1.38-1.71]). SIGNIFICANCE: Older adults with incident epilepsy experience a high burden of polypharmacy at the time of diagnosis, with nearly 90% prescribed five or more drug classes. Certain drug class combinations, such as antipsychotics and antidepressants, were more frequently observed among those with incident epilepsy. These findings underscore the importance of considering overall polypharmacy burden and specific drug class combinations when initiating epilepsy therapy in older adults. PLAIN LANGUAGE SUMMARY: Older adults who develop epilepsy often take many medications for other health conditions. In this study of US Medicare beneficiaries, people who were later diagnosed with epilepsy were taking about nine different types of drug classes in the year before diagnosis, compared with about six drug classes among those who did not develop epilepsy. Certain combinations of drug classes-especially those affecting the brain and nervous system-were more common among people who developed epilepsy. These findings show that many older adults have complex medication regimens when epilepsy is first diagnosed.

Indexed as

AnticonvulsantsEpilepsyPolypharmacyAgedAged, 80 and overFemaleHumansIncidenceLongitudinal StudiesMalePrevalenceRetrospective StudiesUnited StatesAnticonvulsantscomorbiditydrug utilizationhealth services researchincident epilepsypolypharmacy

Identifiers

PMID42390713
PMCPMC13394023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.